Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy

著录项

• 作者

  Garrett, C R; Siu, L L; El-Khoueiry, A; Buter, J; Rocha-Lima, C M; Marshall, J; LoRusso, P; Major, P; Chemidlin, J; Mokliatchouk, O; Velasquez, L; Hayes, W; Feltquate, D; Syed, S; Ford, S; Kollia, G; Galbraith, S; Nuyten, D S A;

  展开▼
• 作者单位

  展开▼
• 年度 2011
• 总页数
• 原文格式 PDF
• 正文语种 {"code":"en","name":"English","id":9}
• 中图分类